# Agilent Technologies Inc. (A)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $36.79B  
**Price:** $129.55 (-1.57%)

> Agilent Technologies Inc. is a life sciences and analytical instruments company that provides application-focused solutions for laboratories and research environments. Agilent Technologies Inc. serves customers in life sciences, diagnostics, and applied chemical markets through a broad portfolio of instruments, software, consumables, and services. Its offerings support testing, measurement, and analysis across pharmaceutical, biotechnology, environmental, food safety, and industrial applications. The company also provides laboratory workflow support and service solutions through its Agilent CrossLab segment, helping organizations maintain and optimize scientific operations. Headquartered in Santa Clara, California, Agilent Technologies Inc. plays an important role in enabling precision research, quality control, and diagnostic testing across scientific and industrial markets.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $6.95B | $3.64B | $1.48B | $1.30B | $4.57 |
| 2024 | $6.51B | $3.54B | $1.49B | $1.29B | $4.43 |
| 2023 | $6.83B | $3.46B | $1.35B | $1.24B | $4.19 |
| 2022 | $6.85B | $3.72B | $1.62B | $1.25B | $4.18 |
| 2021 | $6.32B | $3.41B | $1.35B | $1.21B | $3.94 |
| 2020 | $5.34B | $2.84B | $846M | $719M | $2.30 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $12.73B | $5.99B | $6.74B | $1.79B | $3.05B |
| 2024 | $11.85B | $5.95B | $5.90B | $1.33B | $3.35B |
| 2023 | $10.76B | $4.92B | $5.84B | $1.59B | $2.73B |
| 2022 | $10.53B | $5.23B | $5.30B | $1.05B | $2.73B |
| 2021 | $10.71B | $5.32B | $5.39B | $1.48B | $2.73B |
| 2020 | $9.63B | $4.75B | $4.87B | $1.44B | $2.28B |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $1.51B | -$407M | $1.15B |
| 2024 | $1.74B | -$378M | $1.37B |
| 2023 | $1.50B | -$298M | $1.47B |
| 2022 | $1.24B | -$291M | $1.02B |
| 2021 | $1.56B | -$187M | $1.30B |
| 2020 | $849M | -$118M | $802M |

Source: [CompaniesByCap](https://companiesbycap.com/company/A)